Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has emerged as a promising anticancer agent because of its ability to selectively kill tumor cells. But TRAIL-resistance is a major problem of its therapy. A search for compounds for abrogating TRAIL-resistance has, thus, become an important strategy for anticancer drug discovery. In search of bioactive natural products for overcoming TRAIL-resistance, we previously reported some compounds with TRAIL-resistance overcoming activity. Bioassay guided fractionation of Entada scandens led to the isolation of four compounds (1-4). Of the isolates, compounds 1 and 3 showed moderate TRAIL-resistance overcoming activity in TRAIL-resistant human gastric adenocarcinoma (AGS) cells.
IshibashiM, OhtsukiT. (2008) Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis. Medicinal Research Reviews, 28, 688–714.
2.
ZhangL, FangB. (2005) Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Therapy, 12, 228–237.
3.
CamidgeDR. (2007) The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancer. Clinical Lung Cancer, 8, 413–419.
4.
BaritakiS, Huerta-YepezS, SakaiT, SpandidosDABonavidaB. (2007) Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: Up-regulation of DR5 and inhibition of Yin Yang 1. Molecular Cancer Therapeutics, 6, 1387–1399.
5.
HorinakaM, YoshidaT, ShiraishiT, NakataS, WakadaM, NakanishiR, NishinoH, MatsuiH, SakaiT. (2005) Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells. Oncogene, 24, 7180–7189.
AhmedF, ToumeK, OhtsukiT, RahmanM, SadhuSK, IshibashiM. (2011) Cryptolepine, isolated from Sida acuta, sensitizes human gastric adenocarcinoma cells to TRAIL-induced apoptosis. Phytotherapy Research, 25, 147–150.
8.
MinakawaT, ToumeK, AraiMA, SadhuSK, AhmedF, IshibashiM. (2012) Eudesmane-type sesquiterpenoid and guaianolides from Kandelia candel in a screening program for compounds to overcome TRAIL-resistance. Journal of Natural Products, 75, 1431–1435.
9.
AhmedF, SadhuSK, OhtsukiT, KhatunA, IshibashiM. (2010) Glycosides from Vallaris solanaceae with TRAIL-resistance-overcoming activity. Heterocycles, 80, 477–488.
10.
MinakawaT, ToumeK, AhmedF, SadhuSK, OhtsukiT, AraiM-A, IshibashiM. (2010) Constituents of Pongamia pinnata isolated in a screening for activity to overcome TRAIL-resistance. Chemical and Pharmaceutical Bulletin, 58, 1549–1551.
AhmedF, SadhuSK, IshibashiM. (2010) Search for bioactive natural products from medicinal plants of Bangladesh. Journal of Natural Medicines, 64, 393–401.
BarukialJ, SarmahJN. (2011) Ethnomedicinal plant used by the people of Golaghat district, Assam, India. International Journal of Medicinal and Aromatic Plants, 1, 203–211.
15.
KirtikarKR, BasuBD. (2006) Indian Medicinal Plants. 2nd ed. International Book Distributors, India, 906–908.
16.
OkadaY, SibataS, IkekawaTJavellanaAMJ, KamoO. (1987) Entada saponin-III, a saponin isolated from the bark of Entada phaseoloides.Phytochemistry, 26, 2789–2796.
17.
ZhaoZ-X, JinJ, LinCZ, ZhuCC, LiuYM, LinAH, LiuYX, ZhangLLuoHF. (2011) Two new chalcone glycosides from the stems of Entada phaseoloides. Fitoterapia, 82, 1102–1105.
18.
BaruaAK, ChakrabartyM, DattaPK, RayS. (1988) Phaseoloidin, a homogentisic acid glucoside from Entada phaseoloides.Phytochemistry, 27, 3259–3261.
DaiJKardonoLBSTsauriSPadmawinataKPezzutoJM, KinghornAD. (1991) Phenylacetic acid derivatives and a thioamide glycoside from Entada phaseoloides.Phytochemistry, 30, 3749–3752.
21.
ShankarS, SrivastavaRK. (2004) Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implication. Drug Resistance Updates, 7, 139–156.
22.
OhtsukiT, KikuchiH, KoyanoT, KowithayakornT, SakaiT, IshibashiM. (2009) Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis. Bioorganic & Medicinal Chemistry, 17, 6748–6754.
23.
AhmedF, OhtsukiT, AidaW, IshibashiM. (2008) Tyrosine derivatives Isolated from Streptomyces sp. IFM 10937 in a screening program for TRAIL-resistance-overcoming activity. Journal of Natural Products, 71, 1963–1966.
